Skip to content

Clinical trials

Completed Phase 2 Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 2 Status: Completed Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20052
20062
20071
20082
20101
20112
20121
20131
20161
20171
20182
20191
20202
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
National Heart, Lung, and Blood Institute (NHLBI)3
Actelion1
Assistance Publique - Hôpitaux de Paris1
Bellerophon1
Brigham and Women's Hospital1
Bristol-Myers Squibb1
Centocor, Inc.1
Debiopharm International SA1
Endeavor Biomedicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis28
Idiopathic Pulmonary Fibrosis14
Lung Diseases6
Lung Diseases, Interstitial6
Hypertension, Pulmonary5
Fibrosis3
Idiopathic Interstitial Pneumonias3
Respiratory Tract Diseases3
Pulmonary Arterial Hypertension2
Sarcoidosis2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.